COMMITMENTS AND CONTINGENCIES (Details Narrative)
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
Dec. 20, 2023
USD ($)
Integer
|
Aug. 01, 2023
USD ($)
shares
|
Aug. 31, 2026
USD ($)
|
Aug. 31, 2025
USD ($)
|
Aug. 31, 2024
USD ($)
|
Oct. 31, 2019
USD ($)
|
Jul. 31, 2019
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
Jul. 31, 2026 |
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets, net |
|
|
|
|
|
|
|
$ 17,277,013
|
|
$ 17,277,013
|
|
$ 18,640,673
|
|
| BIAKOS License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for additional royalties |
|
|
|
|
|
|
|
70,265
|
$ 47,935
|
129,146
|
$ 85,435
|
|
|
| BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty percentage |
|
|
|
|
|
|
2.00%
|
|
|
|
|
|
|
| Payment for royalties |
|
|
|
|
|
|
|
|
|
|
|
150,000
|
|
| BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty percentage |
|
|
|
|
|
|
4.00%
|
|
|
|
|
|
|
| BIAKOS Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for additional royalties |
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
| ABF License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase in royalty annual percentage |
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
| ABF License Agreement [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty percentage |
|
|
|
|
|
2.00%
|
|
|
|
|
|
|
|
| Payment for additional royalties |
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
| ABF License Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty percentage |
|
|
|
|
|
4.00%
|
|
|
|
|
|
|
|
| Payment for additional royalties |
|
|
|
|
|
$ 75,000
|
|
|
|
|
|
|
|
| ABF License Agreement [Member] | Maximum [Member] | Product and Service, Other [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for additional royalties |
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
| Debrider License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sales of royalties recognized |
|
|
|
|
|
|
|
|
|
0
|
|
|
|
| Impairment charge |
|
|
|
|
|
|
|
|
|
|
|
1,200,000
|
|
| Intangible assets, net |
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
| BMI License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for royalties |
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
| License Agreement Commitments Description |
|
|
|
|
|
|
|
|
|
the Company was appointed by BMI as the exclusive distributor to promote, market, offer to sell, transfer,
distribute and sell the Products for trauma indications inside the United States and its territories for an initial five-year term, which
term may be automatically renewed for successive two-year periods at the Company’s discretion,
|
|
|
|
| Royalties percentage |
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
| Royalty payments year one |
|
|
|
|
|
|
|
100,000
|
|
$ 100,000
|
|
|
|
| Royalty payments year two |
|
|
|
|
|
|
|
200,000
|
|
200,000
|
|
|
|
| Royalty payments year three |
|
|
|
|
|
|
|
$ 300,000
|
|
300,000
|
|
|
|
| Applied Asset Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Assets purchase price |
|
$ 15,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Installment payable |
|
2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of installment |
|
|
|
$ 625,000
|
$ 625,000
|
|
|
|
|
|
|
|
|
| Assest purchase periodic payment, description |
|
|
|
|
The first, second and third of four installment payments of $625,000
were made in August 2024, 2025 and 2026, respectively.
|
|
|
|
|
|
|
|
|
| Applied Asset Purchase Agreement [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of installment |
|
|
$ 625,000
|
|
|
|
|
|
|
|
|
|
|
| Applied Asset Purchase Agreement [Member] | Cash Closing Consideration [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash consideration paid |
|
$ 9,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Applied Asset Purchase Agreement [Member] | Stock Closing Consideration [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued as consideration | shares |
|
73,809
|
|
|
|
|
|
|
|
|
|
|
|
| Value of shares issued as consideration |
|
$ 3,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
| Applied Asset Purchase Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnout payable |
|
$ 10,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
| Services Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase agreement description |
|
As consideration for the Petito Services, the Owner was entitled to receive: (i) a base salary of $12,000 per month
during the term of the Petito Services Agreement, (ii) a royalty payment equal to 3% of the actual collections from net sales of certain
products the Owner develops or codevelops that reach commercialization, (iii) a royalty payment equal to 5% for the first $50.0 million
in aggregate collections from net sales of certain future products and a royalty payment of 2.5% on aggregate collections from net sales
of certain future products on any amounts exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k)
clearance is issued for any future product accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued
for a certain product; provided that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall
not earn more than $2.5 million.
|
|
|
|
|
|
|
|
|
|
|
|
| License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for royalties |
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Number of unique collagen peptides | Integer |
18
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding units percentage |
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| License Agreement [Member] | Subsequent Event [Member] | Sanara Collagen Peptides, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity ownership interest |
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
| License Agreement [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for additional royalties |
$ 50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty expense percentage |
1.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
| License Agreement [Member] | Minimum [Member] | Royalty Agreement Terms [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for additional royalties |
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| License Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss Contingencies [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty expense percentage |
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|